Avoiding Absolute Quantification Trap: A Novel Predictive Signature of Clinical Benefit to Anti-PD-1 Immunotherapy in Non-Small Cell Lung Cancer

Immunotherapy has been focused on by many oncologists and researchers. While, due to technical biases of absolute quantification, few traditional biomarkers for anti-PD-1 immunotherapy have been applied in regular clinical practice of non-small cell lung cancer (NSCLC). Therefore, there is an urgent...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chengming Liu, Sihui Wang, Sufei Zheng, Fei Xu, Zheng Cao, Xiaoli Feng, Yan Wang, Qi Xue, Nan Sun, Jie He
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/33bd7fb95ba8489280d6f58b400ea218
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!